| 1 | Hypopharyngeal Neoplasms | 37.5% |
| 2 | Hypopharyngeal Cancer | 37.5% |
| 3 | Nasopharyngeal Neoplasms | 37% |
| 4 | Ear Neoplasms | 23% |
| 5 | Nasopharyngeal carcinoma | 22.4% |
| 6 | Laryngeal neoplasm | 18.2% |
| 7 | Pharyngitis | 16.8% |
| 8 | Nose Neoplasms | 15.9% |
| 9 | Nasopharyngitis | 15.3% |
| 10 | Ear Diseases | 12.1% |
| 11 | Lemierre Syndrome | 11.4% |
| 12 | Mouth Neoplasms | 11.4% |
| 13 | Deglutition Disorders | 10.9% |
| 14 | Paranasal Sinus Neoplasms | 10.5% |
| 15 | Laryngeal Diseases | 10.4% |
| 16 | Nose Diseases | 10.4% |
| 17 | Tonsillitis | 9.8% |
| 18 | Parathyroid Neoplasms | 9.3% |
| 19 | Thyroid Neoplasm | 9.3% |
| 20 | Thyroid carcinoma | 9.3% |
| 21 | Retropharyngeal Abscess | 8.5% |
| 22 | Abdominal Neoplasms | 8.3% |
| 23 | Soft Tissue Neoplasms | 8.3% |
| 24 | Thoracic Neoplasms | 8.3% |
| 25 | Tracheal Neoplasms | 8.1% |
| 26 | Acoustic Neuroma | 7.8% |
| 27 | Primary Ciliary Dyskinesia | 7.7% |
| 28 | Digestive System Neoplasms | 7.2% |
| 29 | Endocrine Gland Neoplasms | 7.2% |
| 30 | Eye Neoplasms | 7.2% |
| 31 | Nervous System Neoplasms | 7.2% |
| 32 | Esophageal Neoplasms | 7.1% |
| 33 | Bone neoplasms | 7.1% |
| 34 | Skin Neoplasms | 7.1% |
| 35 | Hematologic Neoplasms | 7.1% |
| 36 | Splenic Neoplasms | 7% |
| 37 | Maxillary Sinus Neoplasms | 6.9% |
| 38 | Salivary Gland Neoplasms | 6.8% |
| 39 | Tongue Neoplasms | 6.8% |
| 40 | Otosclerosis | 6.5% |
| 41 | Tympanosclerosis | 6.5% |
| 42 | Labyrinthitis | 6.5% |
| 43 | Mouth Diseases | 6.1% |
| 44 | Tooth Diseases | 6.1% |
| 45 | Leukoplakia, Oral | 5.7% |
| 46 | Multiple Endocrine Neoplasia | 5.7% |
| 47 | Tympanic Membrane Perforation | 5.7% |
| 48 | Peritonsillar Abscess | 5.6% |
| 49 | Peritoneal Neoplasms | 5.6% |
| 50 | Hamartoma | 5.5% |
| 51 | Neoplasms, Hormone-Dependent | 5.5% |
| 52 | Neoplasms, Multiple Primary | 5.5% |
| 53 | Paraneoplastic Syndromes | 5.5% |
| 54 | Precancerous Conditions | 5.5% |
| 55 | Neoplasms, Second Primary | 5.5% |
| 56 | Granuloma, Lethal Midline | 5.5% |
| 57 | Laryngeal Edema | 5.5% |
| 58 | Nose Deformities, Acquired | 5.5% |
| 59 | Otomycosis | 5.5% |
| 60 | Congenital Microtia | 5.5% |
| 61 | Palatal Neoplasms | 5.5% |
| 62 | Herpes Zoster Oticus | 5.3% |
| 63 | Paraneoplastic Encephalomyelitis | 5.2% |
| 64 | Jaw Diseases | 5.2% |
| 65 | Pharyngeal Diseases | 5.2% |
| 66 | Mammary Neoplasms, Experimental | 5.1% |
| 67 | Thyroid Nodule | 5.1% |
| 68 | Pancreatic Neoplasm | 5% |
| 69 | Laryngitis | 4.8% |
| 70 | Rhinitis | 4.8% |
| 71 | Vocal Cord Dysfunction | 4.8% |
| 72 | Laryngostenosis | 4.7% |
| 73 | Mouth Abnormalities | 4.7% |
| 74 | Nasal Polyps | 4.7% |
| 75 | Dysacusis | 4.7% |
| 76 | Cyst | 4.7% |
| 77 | Neoplastic Processes | 4.7% |
| 78 | Neoplastic Syndromes, Hereditary | 4.7% |
| 79 | Pregnancy Complications, Neoplastic | 4.7% |
| 80 | Neoplasms, Experimental | 4.6% |
| 81 | Parotid Neoplasms | 4.5% |
| 82 | Tooth Loss | 4.4% |
| 83 | Retroperitoneal Neoplasms | 4.4% |
| 84 | Acanthoma | 4.3% |
| 85 | Choanal Atresia | 4.2% |
| 86 | Voice Disorders | 4.2% |
| 87 | Voice Disturbance | 4.2% |
| 88 | Laryngocele | 4.2% |
| 89 | Pharyngeal Neoplasms | 4.2% |
| 90 | Epistaxis | 4.2% |
| 91 | Eyelid Neoplasms | 4.1% |
| 92 | Temporomandibular Joint Disorders | 4.1% |
| 93 | Neoplasms, Radiation-Induced | 4% |
| 94 | Cochlear Diseases | 3.9% |
| 95 | Otitis Externa | 3.9% |
| 96 | Otitis Media | 3.9% |
| 97 | Vestibular Diseases | 3.9% |
| 98 | Endolymphatic Hydrops | 3.9% |
| 99 | Facial Hemiatrophy | 3.8% |
| 100 | Melkersson-Rosenthal Syndrome | 3.8% |
| 101 | Laryngomalacia | 3.7% |
| 102 | Granuloma, Laryngeal | 3.7% |
| 103 | Central Nervous System Neoplasms | 3.7% |
| 104 | Vascular Neoplasms | 3.7% |
| 105 | Thymus Neoplasms | 3.7% |
| 106 | Vocal Cord Paralysis | 3.7% |
| 107 | Genital Neoplasms, Female | 3.7% |
| 108 | Breast Neoplasms, Male | 3.6% |
| 109 | Triple Negative Breast Neoplasms | 3.6% |
| 110 | Carcinoma, Lobular | 3.5% |
| 111 | Testicular Neoplasms | 3.5% |
| 112 | Bell Palsy | 3.3% |
| 113 | Vestibulocochlear Nerve Diseases | 3.3% |
| 114 | Tuberous Sclerosis | 3.3% |
| 115 | Bruxism | 3.3% |
| 116 | Burning Mouth Syndrome | 3.3% |
| 117 | Dental Leakage | 3.3% |
| 118 | Hypercementosis | 3.3% |
| 119 | Lip Diseases | 3.3% |
| 120 | Malocclusion | 3.3% |
| 121 | Microglossia | 3.3% |
| 122 | Oral Submucous Fibrosis | 3.3% |
| 123 | Periodontal Diseases | 3.3% |
| 124 | Salivary Gland Diseases | 3.3% |
| 125 | Stomatitis | 3.3% |
| 126 | Tongue Diseases | 3.3% |
| 127 | Tooth Crowding | 3.3% |
| 128 | Tooth Discoloration | 3.3% |
| 129 | Tooth Demineralization | 3.3% |
| 130 | Oral Ulcer | 3.3% |
| 131 | Tooth Ankylosis | 3.3% |
| 132 | Croup | 3.2% |
| 133 | Rhinitis, Vasomotor | 3.2% |
| 134 | Adrenal Gland Neoplasms | 3.2% |
| 135 | Gastrointestinal Neoplasms | 3.2% |
| 136 | Genital Neoplasms, Male | 3.2% |
| 137 | Liver neoplasms | 3.2% |
| 138 | Uveal Neoplasms | 3.2% |
| 139 | Urologic Neoplasms | 3.2% |
| 140 | Sebaceous Gland Neoplasms | 3.1% |
| 141 | Spinal Neoplasms | 3.1% |
| 142 | Bone Marrow Neoplasms | 3.1% |
| 143 | Trophoblastic Neoplasms | 3.1% |
| 144 | Leukemia, Experimental | 3% |
| 145 | Rhinoscleroma | 3% |
| 146 | Carcinoma, Ehrlich Tumor | 3% |
| 147 | Dermoid Cyst | 3% |
| 148 | Carcinoma, Lewis Lung | 3% |
| 149 | Multiple Endocrine Neoplasia Type 1 | 3% |
| 150 | Liver Neoplasms, Experimental | 2.9% |
| 151 | Carcinoma 256, Walker | 2.9% |
| 152 | Giant Cell Epulis | 2.9% |
| 153 | Tooth Injuries | 2.8% |
| 154 | Sinusitis | 2.8% |
| 155 | Laryngospasm | 2.8% |
| 156 | Erythroplasia | 2.8% |
| 157 | Follicular cyst | 2.8% |
| 158 | leukemia | 2.8% |
| 159 | Mucocele | 2.8% |
| 160 | Neoplasms, Germ Cell and Embryonal | 2.8% |
| 161 | Neoplasms, Glandular and Epithelial | 2.8% |
| 162 | Pilonidal Cyst | 2.8% |
| 163 | Thyroglossal Cyst | 2.8% |
| 164 | Synovial Cyst | 2.8% |
| 165 | Germ Cell Cancer | 2.8% |
| 166 | Aberrant Crypt Foci | 2.8% |
| 167 | Dental Enamel Hypoplasia | 2.8% |
| 168 | Hypodontia | 2.8% |
| 169 | Macrostomia | 2.8% |
| 170 | Microstomia | 2.8% |
| 171 | Salivary Gland Fistula | 2.8% |
| 172 | Thymoma | 2.8% |
| 173 | Facial Nerve Diseases | 2.8% |
| 174 | Maxillary Diseases | 2.8% |
| 175 | Tooth Resorption | 2.8% |
| 176 | Granulomatosis, Orofacial | 2.8% |
| 177 | Hyperacusis | 2.8% |
| 178 | Tinnitus | 2.8% |
| 179 | Phonophobia | 2.8% |
| 180 | Hearing Loss | 2.8% |
| 181 | Cleft Palate | 2.7% |
| 182 | Oral candidiasis | 2.7% |
| 183 | Oral Fistula | 2.7% |
| 184 | Meningioma | 2.7% |
| 185 | Toothache | 2.7% |
| 186 | Lichen Planus, Oral | 2.7% |
| 187 | Leukemia, Radiation-Induced | 2.7% |
| 188 | Jaw Abnormalities | 2.6% |
| 189 | Carcinoma, Pancreatic Ductal | 2.6% |
| 190 | Meniere Disease | 2.6% |
| 191 | Otitis Media with Effusion | 2.6% |
| 192 | Sarcoma, Experimental | 2.6% |
| 193 | Radicular Cyst | 2.5% |
| 194 | ovarian neoplasm | 2.5% |
| 195 | Aphonia | 2.4% |
| 196 | Dysphonia | 2.4% |
| 197 | Neuroectodermal Tumors | 2.4% |
| 198 | Paraneoplastic Cerebellar Degeneration | 2.4% |
| 199 | Nephroblastoma | 2.4% |
| 200 | Leukoplakia | 2.4% |
| 201 | Lymphocele | 2.4% |
| 202 | Pancreatic Cyst | 2.4% |
| 203 | Retrognathia | 2.3% |
| 204 | Facial paralysis | 2.3% |
| 205 | Facial Paresis | 2.3% |
| 206 | Melanoma, Experimental | 2.3% |
| 207 | Barrett Esophagus | 2.3% |
| 208 | Breast Cyst | 2.3% |
| 209 | Histiocytic Disorders, Malignant | 2.3% |
| 210 | Actinic keratosis | 2.3% |
| 211 | Mediastinal Cyst | 2.3% |
| 212 | Neoplasm Invasiveness | 2.3% |
| 213 | Neoplasm Metastasis | 2.3% |
| 214 | Neoplasm Recurrence, Local | 2.3% |
| 215 | Parovarian Cyst | 2.3% |
| 216 | Pericardial Cyst | 2.3% |
| 217 | Thymic Cyst | 2.3% |
| 218 | Carcinogenesis | 2.3% |
| 219 | Myxoid cyst | 2.3% |
| 220 | Metastasis | 2.3% |
| 221 | Hemifacial Spasm | 2.3% |
| 222 | Gingival Hemorrhage | 2.3% |
| 223 | Neoplasms, Neuroepithelial | 2.2% |
| 224 | Gliomatosis cerebri | 2.2% |
| 225 | Limbic Encephalitis | 2.2% |
| 226 | Prognathism | 2.2% |
| 227 | Vestibular Neuronitis | 2.2% |
| 228 | Gingival Recession | 2.1% |
| 229 | Parotitis | 2.1% |
| 230 | Gingival Atrophy | 2.1% |
| 231 | Pituitary Adenoma | 2.1% |
| 232 | Pituitary Neoplasms | 2.1% |
| 233 | Basal Cell Nevus Syndrome | 2.1% |
| 234 | Temporomandibular Joint Dysfunction Syndrome | 2.1% |
| 235 | Kartagener Syndrome | 2.1% |
| 236 | Maxillofacial Abnormalities | 2.1% |
| 237 | Hepatocellular Adenoma | 2% |
| 238 | Meningeal Neoplasms | 2% |
| 239 | Lymphomatoid Granulomatosis | 2% |
| 240 | Lymphoma | 2% |
| 241 | Corpus Luteum Cyst | 2% |
| 242 | Ovarian Cysts | 2% |
| 243 | Hoarseness | 2% |
| 244 | Lambert-Eaton Myasthenic Syndrome | 2% |
| 245 | Cheilitis | 1.9% |
| 246 | Dental caries | 1.9% |
| 247 | Dental Plaque | 1.9% |
| 248 | Dental Pulp Calcification | 1.9% |
| 249 | Drooling | 1.9% |
| 250 | Gingival Diseases | 1.9% |
| 251 | Glossitis | 1.9% |
| 252 | Macroglossia | 1.9% |
| 253 | Periodontitis | 1.9% |
| 254 | Pulpitis | 1.9% |
| 255 | Sialadenitis | 1.9% |
| 256 | Sialometaplasia, Necrotizing | 1.9% |
| 257 | Sialorrhea | 1.9% |
| 258 | Aphthous Stomatitis | 1.9% |
| 259 | Tooth Erosion | 1.9% |
| 260 | Xerostomia | 1.9% |
| 261 | Glossoptosis | 1.9% |
| 262 | Peri-Implantitis | 1.9% |
| 263 | Retinoblastoma | 1.9% |
| 264 | Carcinosarcoma | 1.9% |
| 265 | Hemangiosarcoma | 1.9% |
| 266 | Leukemia L1210 | 1.9% |
| 267 | Leukemia P388 | 1.9% |
| 268 | lymphangiosarcoma | 1.9% |
| 269 | Vertigo | 1.9% |
| 270 | Mastoiditis | 1.8% |
| 271 | Petrositis | 1.8% |
| 272 | Deafness | 1.8% |
| 273 | Hearing Loss, Sudden | 1.8% |
| 274 | Hearing Loss, Bilateral | 1.8% |
| 275 | Hearing Loss, High-Frequency | 1.8% |
| 276 | Hearing Loss, Mixed Conductive-Sensorineural | 1.8% |
| 277 | Hearing Loss, Unilateral | 1.8% |
| 278 | Complete Hearing Loss | 1.8% |
| 279 | Deaf Mutism | 1.8% |
| 280 | Composite Lymphoma | 1.8% |
| 281 | Prolactinoma | 1.8% |
| 282 | Growth Hormone-Secreting Pituitary Adenoma | 1.8% |
| 283 | Opsoclonus-Myoclonus Syndrome | 1.8% |
| 284 | Lung Neoplasms | 1.8% |
| 285 | Pleural Neoplasms | 1.8% |
| 286 | Choledochal Cyst | 1.8% |
| 287 | Brain Neoplasms | 1.7% |
| 288 | Spinal Cord Neoplasms | 1.7% |
| 289 | Peutz-Jeghers Syndrome | 1.7% |
| 290 | melanoma | 1.7% |
| 291 | Uterine Neoplasms | 1.7% |
| 292 | Vaginal Neoplasms | 1.7% |
| 293 | Vulvar Neoplasms | 1.7% |
| 294 | Uterine Cancer | 1.7% |
| 295 | Fallopian Tube Neoplasms | 1.7% |
| 296 | Choriocarcinoma | 1.7% |
| 297 | insulinoma | 1.7% |
| 298 | Tooth Avulsion | 1.6% |
| 299 | Behcet Syndrome | 1.6% |
| 300 | Myelitis, Transverse | 1.6% |
| 301 | Dental Pulp Necrosis | 1.6% |
| 302 | Facial Neuralgia | 1.6% |
| 303 | Dental Fistula | 1.6% |
| 304 | Oroantral Fistula | 1.6% |
| 305 | Leukemia, Plasma Cell | 1.6% |
| 306 | Adenomatous Polyposis Coli | 1.6% |
| 307 | Hay fever | 1.6% |
| 308 | Rhinitis, Allergic, Perennial | 1.6% |
| 309 | Sarcoma 180 | 1.6% |
| 310 | Micrognathism | 1.6% |
| 311 | Pierre Robin Syndrome | 1.6% |
| 312 | granulosa cell tumor | 1.6% |
| 313 | Carcinoma, Ovarian Epithelial | 1.6% |
| 314 | Tonsillar Neoplasms | 1.6% |
| 315 | Gastrinoma | 1.6% |
| 316 | Glucagonoma | 1.6% |
| 317 | Vipoma | 1.6% |
| 318 | Central Nervous System Cysts | 1.5% |
| 319 | Bile Duct Neoplasms | 1.5% |
| 320 | gallbladder neoplasm | 1.5% |
| 321 | Intestinal Neoplasms | 1.5% |
| 322 | Penile Neoplasms | 1.5% |
| 323 | Prostatic Neoplasms | 1.5% |
| 324 | Stomach Neoplasms | 1.5% |
| 325 | Polycythemia Vera | 1.5% |
| 326 | Adenoma | 1.5% |
| 327 | Ameloblastoma | 1.5% |
| 328 | Angiokeratoma | 1.5% |
| 329 | Carcinoma | 1.5% |
| 330 | Chordoma | 1.5% |
| 331 | Hemangioma | 1.5% |
| 332 | hemangiopericytoma | 1.5% |
| 333 | Lymphangioma | 1.5% |
| 334 | Mesenchymoma | 1.5% |
| 335 | Nevus | 1.5% |
| 336 | Teratoma | 1.5% |
| 337 | Hepatoblastoma | 1.5% |
| 338 | Mixed Tumor, Mullerian | 1.5% |
| 339 | Germinoma | 1.5% |
| 340 | Teratocarcinoma | 1.5% |
| 341 | Angiofibroma | 1.5% |
| 342 | Sarcoma | 1.5% |
| 343 | Epithelioma | 1.5% |
| 344 | Mesoblastic Nephroma | 1.4% |
| 345 | Vesicular Stomatitis | 1.4% |
| 346 | Sleep Bruxism | 1.4% |
| 347 | Bladder Neoplasm | 1.4% |
| 348 | Kidney Neoplasm | 1.4% |
| 349 | Ureteral Neoplasms | 1.4% |
| 350 | Urethral Neoplasms | 1.4% |
| 351 | Basal cell carcinoma | 1.3% |
| 352 | Carcinoma, Papillary | 1.3% |
| 353 | Squamous cell carcinoma | 1.3% |
| 354 | Chondrosarcoma | 1.3% |
| 355 | Craniopharyngioma | 1.3% |
| 356 | Cystadenoma | 1.3% |
| 357 | leiomyosarcoma | 1.3% |
| 358 | liposarcoma | 1.3% |
| 359 | Mesothelioma | 1.3% |
| 360 | synovial sarcoma | 1.3% |
| 361 | Neuroectodermal Tumor, Melanotic | 1.3% |
| 362 | Angiomyolipoma | 1.3% |
| 363 | Clear Cell Sarcoma of Soft Tissue | 1.3% |
| 364 | Alveolar Soft Part Sarcoma | 1.3% |
| 365 | Neuroendocrine Tumors | 1.3% |
| 366 | Sarcoma, Myeloid | 1.3% |
| 367 | Carcinoma, Basal Cell | 1.3% |
| 368 | Leydig Cell Tumor | 1.3% |
| 369 | Auditory Perceptual Disorders | 1.3% |
| 370 | Gingivitis | 1.3% |
| 371 | Glossitis, Benign Migratory | 1.3% |
| 372 | Pericoronitis | 1.3% |
| 373 | Aggressive Periodontitis | 1.3% |
| 374 | Gingival Overgrowth | 1.3% |
| 375 | Adenoma, Acidophil | 1.3% |
| 376 | Ganglioneuroma | 1.3% |
| 377 | Glioma | 1.3% |
| 378 | Optic Nerve Glioma | 1.3% |
| 379 | Malignant Glioma | 1.3% |
| 380 | Mobius Syndrome | 1.2% |
| 381 | Pancreatic Pseudocyst | 1.2% |
| 382 | Plasmacytoma | 1.2% |
| 383 | Herpes Labialis | 1.2% |
| 384 | Malignant histiocytosis | 1.2% |
| 385 | Lymphatic Metastasis | 1.2% |
| 386 | Neoplasms, Unknown Primary | 1.2% |
| 387 | Leukemic Infiltration | 1.2% |
| 388 | Histiocytic sarcoma | 1.2% |
| 389 | Neoplasm Micrometastasis | 1.2% |
| 390 | Meningeal Carcinomatosis | 1.2% |
| 391 | Endometrial Stromal Sarcoma | 1.2% |
| 392 | Xeroderma Pigmentosum | 1.2% |
| 393 | Medulloblastoma | 1.1% |
| 394 | Facial Nerve Injuries | 1.1% |
| 395 | Alveolar Bone Loss | 1.1% |
| 396 | Trigeminal Nerve Disorder | 1.1% |
| 397 | Adrenocortical carcinoma | 1.1% |
| 398 | Cystadenocarcinoma | 1.1% |
| 399 | Fibrosarcoma | 1.1% |
| 400 | Osteosarcoma | 1.1% |
| 401 | Mucoepidermoid Carcinoma | 1.1% |
| 402 | Bronchial Neoplasms | 1.1% |
| 403 | Multiple Pulmonary Nodules | 1% |
| 404 | Hodgkin Disease | 1% |
| 405 | Lymphoma, Non-Hodgkin | 1% |
| 406 | Polycystic Ovary Syndrome | 1% |
| 407 | Supratentorial Neoplasms | 1% |
| 408 | Carcinoid Tumor | 1% |
| 409 | Endometrial Neoplasms | 1% |
| 410 | Neurilemmoma | 1% |
| 411 | Hutchinson's Melanotic Freckle | 1% |
| 412 | Melanoma, Amelanotic | 1% |
| 413 | Lymphangioleiomyomatosis | 1% |
| 414 | Denys-Drash Syndrome | 1% |
| 415 | Toxic Epidermal Necrolysis | 1% |
| 416 | Stevens-Johnson Syndrome | 1% |
| 417 | Gingival Hyperplasia | 1% |
| 418 | Gingival Hypertrophy | 1% |
| 419 | Renal Cell Carcinoma | 1% |
| 420 | Papillary Renal Cell Carcinoma | 1% |
| 421 | Adenofibroma | 0.9% |
| 422 | Fibroadenoma | 0.9% |
| 423 | Malignant Fibrous Histiocytoma | 0.9% |
| 424 | Primary amyloidosis | 0.9% |
| 425 | Hydatidiform Mole | 0.9% |
| 426 | Pleural Effusion, Malignant | 0.9% |
| 427 | Prostatic Neoplasms, Castration-Resistant | 0.9% |
| 428 | Nelson Syndrome | 0.9% |
| 429 | Cecal Neoplasms | 0.8% |
| 430 | Duodenal Neoplasms | 0.8% |
| 431 | Adenocarcinoma | 0.8% |
| 432 | Carcinoma in Situ | 0.8% |
| 433 | Carcinoma, Transitional Cell | 0.8% |
| 434 | Phyllodes Tumor | 0.8% |
| 435 | Dysgerminoma | 0.8% |
| 436 | Hemangioendothelioma | 0.8% |
| 437 | Lipoma | 0.8% |
| 438 | Myoma | 0.8% |
| 439 | Myxoma | 0.8% |
| 440 | Neuroma | 0.8% |
| 441 | Papilloma | 0.8% |
| 442 | Pseudomyxoma Peritonei | 0.8% |
| 443 | Seminoma | 0.8% |
| 444 | Papillomatosis | 0.8% |
| 445 | Angiolipoma | 0.8% |
| 446 | Myelolipoma | 0.8% |
| 447 | Neoplasms, Bone Tissue | 0.8% |
| 448 | Neoplasms, Fibrous Tissue | 0.8% |
| 449 | Smooth Muscle Tumor | 0.8% |
| 450 | Adenomatosis, Pulmonary | 0.8% |
| 451 | Adenomatous Polyps | 0.8% |
| 452 | Carcinoma, Large Cell | 0.8% |
| 453 | Carcinoma, Small Cell | 0.8% |
| 454 | Desmoplastic Small Round Cell Tumor | 0.8% |
| 455 | Chondroma | 0.8% |
| 456 | Enchondroma | 0.8% |
| 457 | Bowen's Disease | 0.8% |
| 458 | Mumps | 0.8% |
| 459 | Paraganglioma | 0.8% |
| 460 | Rhabdomyosarcoma | 0.8% |
| 461 | Trigeminal Neuralgia | 0.8% |
| 462 | Giant Cell Tumor of Bone | 0.8% |
| 463 | Astrocytoma | 0.8% |
| 464 | Ependymoma | 0.8% |
| 465 | oligodendroglioma | 0.8% |
| 466 | Ganglioglioma | 0.8% |
| 467 | gliosarcoma | 0.8% |
| 468 | Anaplastic astrocytoma | 0.8% |
| 469 | Anaplastic Oligodendroglioma | 0.8% |
| 470 | Waldenstrom Macroglobulinemia | 0.7% |
| 471 | Multiple Myeloma | 0.7% |
| 472 | Colorectal Neoplasms | 0.7% |
| 473 | Carcinoma, Endometrioid | 0.7% |
| 474 | Neurofibrosarcoma | 0.7% |
| 475 | Ulcerative stomatitis | 0.7% |
| 476 | Brain Stem Neoplasms | 0.7% |
| 477 | Malignant Carcinoid Syndrome | 0.7% |
| 478 | Leukemia, Myelomonocytic, Chronic | 0.7% |
| 479 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.7% |
| 480 | Zollinger-Ellison syndrome | 0.7% |
| 481 | Dermatofibrosarcoma | 0.7% |
| 482 | Dermatofibrosarcoma Protuberans | 0.7% |
| 483 | Sicca Syndrome | 0.6% |
| 484 | Sjogren's Syndrome | 0.6% |
| 485 | Cerebellar Neoplasms | 0.6% |
| 486 | Mastocytosis | 0.6% |
| 487 | Sturge-Weber Syndrome | 0.6% |
| 488 | Cell Transformation, Viral | 0.6% |
| 489 | Gastrointestinal Stromal Tumors | 0.6% |
| 490 | Hemangioma, Cavernous | 0.6% |
| 491 | Leukemia, T-Cell | 0.6% |
| 492 | Leukemia, B-Cell | 0.6% |
| 493 | neurofibroma | 0.6% |
| 494 | Lymphoma, Follicular | 0.6% |
| 495 | T-Cell Lymphoma | 0.6% |
| 496 | Mantle cell lymphoma | 0.6% |
| 497 | Glioblastoma | 0.6% |
| 498 | Neuroblastoma | 0.6% |
| 499 | Glioblastoma Multiforme | 0.6% |
| 500 | Pheochromocytoma | 0.5% |
| 501 | Alveolar rhabdomyosarcoma | 0.5% |
| 502 | Appendiceal Neoplasms | 0.5% |
| 503 | Colonic Neoplasms | 0.5% |
| 504 | Rectal Neoplasms | 0.5% |
| 505 | Choroid Plexus Papilloma | 0.5% |
| 506 | Adenoid Cystic Carcinoma | 0.5% |
| 507 | fibroma | 0.5% |
| 508 | Fibromatosis | 0.5% |
| 509 | Osteoblastoma | 0.5% |
| 510 | Osteoma | 0.5% |
| 511 | Rhabdomyoma | 0.5% |
| 512 | Chondromatosis | 0.5% |
| 513 | Adenocarcinoma, Clear Cell | 0.5% |
| 514 | Cholangiocarcinoma | 0.5% |
| 515 | Cervical Intraepithelial Neoplasia | 0.5% |
| 516 | Hemangioblastoma | 0.5% |
| 517 | Lymphoma, Extranodal NK-T-Cell | 0.5% |
| 518 | Ganglioneuroblastoma | 0.5% |
| 519 | Carcinoid Heart Disease | 0.5% |
| 520 | Mastocytoma | 0.4% |
| 521 | Mastocytosis, Systemic | 0.4% |
| 522 | Leukemia, Myeloid, Chronic-Phase | 0.4% |
| 523 | Anus Neoplasms | 0.4% |
| 524 | Sigmoid Neoplasms | 0.4% |
| 525 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.3% |
| 526 | Leukemia, Large Granular Lymphocytic | 0.3% |
| 527 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.3% |
| 528 | Lymphoma, T-Cell, Cutaneous | 0.3% |
| 529 | Lymphoma, AIDS-Related | 0.3% |
| 530 | Enteropathy-Associated T-Cell Lymphoma | 0.3% |
| 531 | Primary Effusion Lymphoma | 0.3% |
| 532 | Fibromatosis, Aggressive | 0.3% |
| 533 | Fibromatosis, Abdominal | 0.3% |
| 534 | Klatskin Tumor | 0.3% |
| 535 | Burkitt Lymphoma | 0.3% |
| 536 | Dupuytren Contracture | 0.2% |
| 537 | Urticaria Pigmentosa | 0.2% |
| 538 | Mycosis Fungoides | 0.2% |
| 539 | Lymphomatoid Papulosis | 0.2% |
| 540 | Plasmablastic lymphoma | 0.2% |
| 541 | Sezary Syndrome | 0.2% |